CLINICAL_TRIALS
trial_result
· 2016-01-25
Clinical Trial Update: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy [Phase 3]
Summary
Phase 3 trial assessing cinacalcet for hypercalcemia in primary hyperparathyroidism patients unable to undergo parathyroidectomy; results completed with posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Hyperparathyroidism, Primary, Hypercalcemia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-25